Colony formation experiments revealed the sh-ADM + sorafenib group formed substantially fewer colonies than the sh-NC + sorafenib group (Figure 5I), confirming ADM knockdown markedly enhances sorafenib’s capacity to inhibit hepatocellular carcinoma cell proliferation. This evidence concerns the gene ADM and hepatocellular carcinoma.